The Safety and Effectiveness of Didanosine Plus Stavudine Plus Delavirdine Mesylate Plus MKC-442 in HIV-Infected Patients Who Have Not Had Success With Protease Inhibitors
Clinical trial NCT00002420 · TERMINATED
Trial details
- NCT number
- NCT00002420
- Sponsor
- Bristol-Myers Squibb
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.